Location of Repository

Inflammatory Profiles in Chronic Obstructive Pulmonary Disease and Asthma

By Shironjit K. Saha

Abstract

Historically, asthma and chronic obstructive pulmonary disease (COPD) represent polar ends of the spectrum of airways disease defined in part by distinctive profiles of airway inflammation; in practice, overlap can exist between asthma and COPD. This thesis examined the pattern of inflammatory cell infiltration and cytokine expression within the bronchus in COPD and asthma with further study of moderate-severe asthma. In addition using sputum, cytokine expression was further assessed in COPD and asthma and its relation to severity. Based on previous studies, this thesis examined the expression of specifically Interleukin (IL)-13 and Granulocyte Macrophage Colony Stimulating Factor (GMCSF). \ud We demonstrated mast cell myositis in moderate and severe asthma which reflected increased disease symptoms. Preferential localization of inflammatory cells to airway smooth muscle (ASM) was absent in COPD. CD3+ T-cells infiltration of large airway glands was increased in COPD which may influence mucus hyper-secretion. \ud We demonstrated IL-13 overexpression within the submucosa in moderate-severe asthma with specific increase in the ASM in severe disease. IL-13 expression was related to eosinophilic inflammation. In sputum, IL-13 protein was increased in mild and severe asthma reflecting IL-13 expression in ASM. There was a general absence of bronchus and sputum IL-13 in COPD. \ud Sputum GMCSF was increased in moderate-severe asthma and mild-severe COPD. Parallel upregulation of GMCSF and associated receptor (GMCSFr) expression in the submucosa and ASM was present in severe asthma. GMCSF/GMCSFr expression did not exhibit preferential expression in the large airway of COPD. \ud Our findings suggest inflammatory cell infiltration of the airway structures is present in asthma and COPD which may influence the phenotype. In addition IL-13 is important in severe asthma whilst GMCSF is expressed in asthma and COPD across a range of severity, but to a greater degree in severe asthma

Publisher: University of Leicester
Year: 2010
OAI identifier: oai:lra.le.ac.uk:2381/8206

Suggested articles

Preview

Citations

  1. (2003). 13 expression is co-localized to mast cells within the airway smooth muscle in asthma. Clin Exp Allergy
  2. (1991). A bronchial epithelial cellderived factor in asthma that promotes eosinophil activation and survival as GM-CSF",
  3. (2000). A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children",
  4. (1992). A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial.
  5. (1992). A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial",
  6. (1999). A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo",
  7. (1969). A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema",
  8. (2008). A double-blind, placebo-controlled, study to assess the pharmacokinetics, safety and tolerability of multiple ascending intravenous doses of CAT 354, a recombinant human anti-IL13 antibody, in subjects with moderate asthma. ERS Abstract.
  9. (1991). A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF",
  10. (1996). A novel action of IL-13: induction of diminished monocyte glucocorticoid receptorbinding affinity",
  11. (1993). Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis
  12. (1993). Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis",
  13. (1996). Activation of human eosinophils by IL-13. Induction of CD69 surface antigen, its relationship to messenger RNA expression, and promotion of cellular viability",
  14. (1995). Adhesion of activated eosinophils to respiratory epithelial cells is enhanced by tumor necrosis factor-alpha and interleukin-1 beta",
  15. (1991). Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules",
  16. (2000). Adhesion of human lung mast cells to bronchial epithelium: evidence for a novel carbohydrate-mediated mechanism",
  17. (2008). Advances in asthma and allergy genetics in 2007",
  18. (2006). Airflow limitation and airway dimensions in chronic obstructive pulmonary disease",
  19. (1994). Airway eosinophilia in chronic bronchitis during exacerbations",
  20. (2001). Airway epithelial cells release eosinophil survival-promoting factors (GM-CSF) after stimulation of proteinaseactivated receptor 2",
  21. (2008). Airway hyperresponsiveness is dissociated from airway wall structural remodeling",
  22. (2006). Airway inflammation and cellular stress in noneosinophilic atopic asthma",
  23. (2002). Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. Am J Respir Crit Care Med
  24. (1993). Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis
  25. (1993). Airway mucosal inflammation even in patients with newly diagnosed asthma",
  26. (2008). Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology",
  27. (2004). Airway remodeling: a comparison between fatal and nonfatal asthma.
  28. (2004). Airway remodeling: a comparison between fatal and nonfatal asthma",
  29. (2004). Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD",
  30. (2006). Airway smooth muscle and mast cell-derived CC chemokine ligand 19 mediate airway smooth muscle migration in asthma",
  31. (2000). Airway smooth muscle function in asthma",
  32. (2000). Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices",
  33. (1998). Airway wall thickness in patients with near fatal asthma and control groups: assessment with high resolution computed tomographic scanning",
  34. (1996). Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils",
  35. (2002). Alterations in airway inflammation and lung function during corticosteroid therapy for atopic asthma",
  36. (2006). American Thoracic Society
  37. (2000). American Thoracic Society (ATS)
  38. (2005). Amphiregulin expression in human mast cells and its effect on the primary human lung fibroblasts",
  39. (2001). Amplification of inflammation in emphysema and its association with latent adenoviral infection",
  40. (1999). An IL-13 promoter polymorphism associated with increased risk of allergic asthma",
  41. (2005). Antigen-specific CD4+ T cells drive airway smooth muscle remodeling in experimental asthma",
  42. (2007). Antiinflammatory activity of beta2-agonists in primary lung epithelial cells is independent of glucocorticoid receptor",
  43. (2006). Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease",
  44. (2003). Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease",
  45. (2003). Applying stereology to measure thickness of the basement membrane zone in bronchial biopsy specimens",
  46. (2007). Aspects on pathophysiological mechanisms in COPD",
  47. (2004). Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a metaanalysis",
  48. (2008). Association of mast cells with lung function in chronic obstructive pulmonary disease",
  49. (2002). Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial",
  50. (2002). Attenuation of airway hyperresponsiveness in a murine asthma model by neutralization of granulocyte-macrophage colony-stimulating factor (GM-CSF)",
  51. (2006). Attenuation of human lung mast cell degranulation by bronchial epithelium",
  52. (2000). Attenuation of the allergen-induced late asthmatic reaction by cyclosporin A is associated with inhibition of bronchial eosinophils, interleukin-5, granulocyte macrophage colony-stimulating factor, and eotaxin",
  53. (1995). Blood eosinophil leukotriene C4 production in asthma of different severities",
  54. (2006). Brightling CE. Airway smooth muscle and mast cell-derived CC chemokine ligand 19 mediate airway smooth muscle migration in asthma. Am J Respir Crit Care Med
  55. (1990). Bronchial epithelial cells exposed to isocyanates potentiate activation and proliferation of T-cells",
  56. (1982). Bronchial hyperreactivity in chronic obstructive bronchitis",
  57. (2003). Bronchial hyperresponsiveness and airway inflammation in adolescents with asymptomatic childhood asthma",
  58. (2007). Bronchial inflammation and airway responses to deep inspiration in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med
  59. (2007). Bronchial inflammation and airway responses to deep inspiration in asthma and chronic obstructive pulmonary disease",
  60. (1997). Bronchial mucosal
  61. (1997). Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids",
  62. (1993). CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines",
  63. (1999). CD69 surface expression on human lung eosinophils after segmental allergen provocation",
  64. (1998). CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease",
  65. (1996). Cell cultures from bronchial subepithelial myofibroblasts enhance eosinophil survival in vitro",
  66. (1991). Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma",
  67. (1997). Cellular profiles in asthmatic airways: a comparison of induced sputum, bronchial washings, and bronchoalveolar lavage fluid",
  68. (2001). Changes in bronchial inflammation during acute exacerbations of chronic bronchitis",
  69. (1998). Changes in CD11b and L-selectin expression on eosinophils are mediated by human lung fibroblasts in vitro",
  70. (2004). Chemokine concentrations in induced sputum and bronchoalveolar lavage in eosinophilic bronchitis, asthma, and normal controls.
  71. (1989). Chronic cough: eosinophilic bronchitis without asthma",
  72. (2002). Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism",
  73. (2005). Cigarette smoke induces IL-8, but inhibits eotaxin and RANTES release from airway smooth muscle",
  74. (2003). Clinical and biological heterogeneity in children with moderate asthma",
  75. (2004). Clinical assessment of airway remodeling in asthma: utility of computed tomography",
  76. (2008). Clinical Asthma.
  77. (2002). Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study",
  78. (2003). Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax
  79. (2003). Comparison of airway immunopathology of eosinophilic bronchitis and asthma",
  80. (1997). Comparison of sputum and serum eosinophil cationic protein (ECP) levels in nonatopic asthma and chronic obstructive pulmonary disease",
  81. (1996). Compartmentalization of eosinophil granulocytemacrophage colony-stimulating factor expression in patients with asthma",
  82. (1998). Compartmentalized transgene expression of granulocyte-macrophage colonystimulating factor (GM-CSF) in mouse lung enhances allergic airways inflammation",
  83. (2002). Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells",
  84. (2006). Cooperative molecular and cellular networks regulate Toll-like receptor-dependent inflammatory responses",
  85. (2001). Correlation between airway hyperresponsiveness and airway inflammation in a young adult population: eosinophil, ECP, and cytokine levels in induced sputum",
  86. (2004). Correlation of allergen-induced IL-5 and IL-13 production by peripheral blood T cells of asthma patients",
  87. (2004). Cough is an airway itch?",
  88. (2008). Cross-talk between ICAM-1 and granulocyte-macrophage colony-stimulating factor receptor signaling modulates eosinophil survival and activation",
  89. (2003). CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4",
  90. (1997). Cytokine concentrations in sputum from patients with cystic fibrosis and their relation to eosinophil activity",
  91. (1996). Cytokine production by cell cultures from bronchial subepithelial myofibroblasts",
  92. (1999). Cytokine profiles of BAL T cells and T-cell clones obtained from human asthmatic airways after local allergen challenge",
  93. (2006). Cytokine-activated bronchial epithelial cell pro-inflammatory functions are effectively downregulated in vitro by ciclesonide",
  94. (1992). Cytokines in symptomatic asthma airways",
  95. (2006). Cytokines or their antagonists for the treatment of asthma",
  96. (1994). Decline of lung function in adults with bronchial asthma",
  97. (2008). Decreased cytokine and chemokine mRNA expression in bronchoalveolar lavage in asymptomatic smoking subjects",
  98. (2004). Decreased expression of interleukin 13 in human lung emphysema",
  99. (2001). Decreased steroid responsiveness at night in nocturnal asthma. Is the macrophage responsible?",
  100. (2000). Delayed eosinophil apoptosis in asthma",
  101. Demonstration of cellular source of granulocyte macrophage colony-stimulating factor by in situ hybridization",
  102. (2004). Dendritic cells retrovirally overexpressing IL-12 induce strong Th1 responses to inhaled antigen in the lung but fail to revert established Th2 sensitization",
  103. (1993). Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids",
  104. (1999). Development and validation of a questionnaire to measure asthma control",
  105. (1999). Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma",
  106. (2008). Differences in airway cytokine profile in severe asthma compared to moderate asthma",
  107. (2006). Differences in airway wall remodelling in asthma and EB",
  108. (1996). Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma",
  109. (2005). Differential expression of CCR3 and CXCR3 by human lung and bone marrow-derived mast cells: implications for tissue mast cell migration",
  110. (2002). Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma",
  111. (2001). Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells",
  112. (2002). Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur Respir J
  113. (2002). Distribution and degranulation of airway mast cells in normal and asthmatic subjects",
  114. (1994). Distribution of receptors for granulocyte-macrophage colony-stimulating factor on immature CD34+ bone marrow cells, differentiating monomyeloid progenitors, and mature blood cell subsets",
  115. (1992). Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma",
  116. (2007). Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies",
  117. (2003). Effect of cilomilast (Ariflo) on TNF-alpha, IL-8, and GM-CSF release by airway cells of patients with COPD",
  118. (1994). Effect of inhaled beclomethasone dipropionate on expression of proinflammatory cytokines and activated eosinophils in the bronchial epithelium of patients with mild asthma",
  119. (1999). Effect of inhaled glucocorticoid on the cellular profile and cytokine levels in induced sputum from asthmatic patients",
  120. (2000). Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease",
  121. (1994). Effects of a corticosteroid, budesonide, on alveolar macrophage and blood monocyte secretion of cytokines: differential sensitivity of GM-CSF,
  122. (1995). Effects of allergen challenge on eosinophils, eosinophil cationic protein, and granulocytemacrophage colony-stimulating factor in mild asthma",
  123. (2000). Effects of budesonide and formoterol on eosinophil activation induced by human lung fibroblasts",
  124. (2001). Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma",
  125. (2001). Effects of formoterol and budesonide on GMCSF and IL-8 secretion by triggered human bronchial epithelial cells",
  126. (1988). Effects of granulocyte-macrophage colony-stimulating factor and colony-stimulating factor-1 on the proliferation and differentiation of murine alveolar macrophages",
  127. (2005). Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease",
  128. (2006). Effects of smoking cessation on lung function and airway inflammation in smokers with asthma",
  129. (2004). Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma",
  130. (2002). Effects of varying doses of fluticasone propionate on the physiology and bronchial wall immunopathology in mild-to-moderate asthma",
  131. (2004). Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD: a pilot study",
  132. (2001). Efficacy of soluble IL-4 receptor for the treatment of adults with asthma",
  133. (1997). Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma",
  134. (1991). Endobronchial allergen challenge in asthma.
  135. (1996). Endobronchial secretion of interleukin-13 following local allergen challenge in atopic asthma: relationship to interleukin-4 and eosinophil counts",
  136. (2000). Eosinophil activation status and corticosteroid responsiveness in severe asthma",
  137. (1997). Eosinophil adhesion to human bronchial epithelial cells: regulation by cytokines",
  138. (1999). Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics",
  139. (1996). Eosinophil degranulation in the presence of bronchial epithelial cells. Effect of cytokines and role of adhesion",
  140. (1996). Eosinophil peroxidase stimulates the release of granulocyte-macrophage colony-stimulating factor from bronchial epithelial cells",
  141. (2006). Eosinophil-mediated cholinergic nerve remodeling",
  142. (2003). Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway",
  143. (1990). Eosinophilia in transgenic mice expressing interleukin 5", J.Exp.Med.,
  144. (2007). Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial",
  145. (2006). Eosinophilic airway inflammation in COPD",
  146. (1993). Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease",
  147. (1999). Eosinophilic bronchitis is an important cause of chronic cough",
  148. (1999). Eosinophilic inflammation in stable chronic obstructive pulmonary disease.
  149. (2002). Eosinophils express functional IL-13 in eosinophilic inflammatory diseases",
  150. (1992). Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics",
  151. (2000). Eosinophils in asthma and other allergic diseases",
  152. (2007). Eotaxin-2 in sputum cell culture to evaluate asthma inflammation",
  153. (2002). Epidemiological studies in mucus hypersecretion",
  154. (2006). Epidemiology of chronic obstructive pulmonary disease: health effects of air pollution",
  155. (2000). Epithelial desquamation in asthma: artifact or pathology?",
  156. (2006). Epithelial mucin stores are increased in the large airways of smokers with airflow obstruction",
  157. (2000). Epithelial-mesenchymal interactions in the pathogenesis of asthma",
  158. (2001). Erythromycin modulates eosinophil chemotactic cytokine production by human lung fibroblasts in vitro",
  159. (2006). Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients",
  160. (2006). Evidence of a role of tumor necrosis factor alpha in refractory asthma",
  161. (1999). Exposure to systemic prednisolone for 4 hours reduces ex vivo synthesis of GM-CSF by bronchoalveolar lavage cells and blood mononuclear cells of mild allergic asthmatics",
  162. (1994). Expression and function of the MAdCAM-1 receptor, integrin alpha 4 beta 7, on human leukocytes",
  163. (1992). Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colonystimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha",
  164. (1998). Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids",
  165. (1997). Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy",
  166. (1997). Expression of interleukin-5 and granulocyte-macrophage colony-stimulating factor in aspirin-sensitive and non-aspirin-sensitive asthmatic airways",
  167. (1991). Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils",
  168. (2000). Expression of P-selectin at low site density promotes selective attachment of eosinophils over neutrophils",
  169. (1992). Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma",
  170. (2001). Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis",
  171. (2005). FcepsilonRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells",
  172. (2004). Fluticasone induces T cell apoptosis in the bronchial wall of mild to moderate asthmatics",
  173. (1998). Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time",
  174. for Clinical Excellence. Chronic obstructive pulmonary disease: Management of chronic obstructive pulmonary disease in adults in primary and secondary care.
  175. (1984). for Standardization in Haematology
  176. (2006). Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma.
  177. (2006). Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma",
  178. (1996). Functional and structural characterization of the eosinophil P-selectin ligand",
  179. (2006). Functional KCa3.1 K+ channels are required for human lung mast cell migration",
  180. (1993). Functional significance of increased airway smooth muscle in asthma and COPD",
  181. (1986). Further specification and evaluation of a new clinical index for dyspnea",
  182. (1996). Gene expression of interleukin-3 and granulocyte macrophage colony-stimulating factor in circulating CD4+ T cells in acute severe asthma",
  183. (2000). Genetic variants of IL-13 signalling and human asthma and atopy",
  184. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management, and Prevention of COPD.
  185. (2000). Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma",
  186. (1998). Glucocorticoid receptors in bronchial epithelial cells in asthma",
  187. (1998). Glucocorticoid regulation of GM-CSF: evidence for transcriptional mechanisms in airway epithelial cells",
  188. (1991). Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor",
  189. (1992). Glucocorticoids inhibit granulocyte-macrophage colony-stimulating factor-1 and interleukin-5 enhanced in vitro survival of human eosinophils",
  190. (2003). GM-CSF increases airway smooth muscle cell connective tissue expression by inducing TGF-beta receptors",
  191. (1997). Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects",
  192. (2001). Granulocyte macrophage-colony-stimulating factor mRNA is stabilized in airway eosinophils and peripheral blood eosinophils activated by TNF-alpha plus fibronectin",
  193. (1995). Granulocyte-macrophage colony-stimulating factor increases 5-lipoxygenase gene transcription and protein expression in human neutrophils",
  194. (2008). Granulocyte-macrophage colony-stimulating factor is required for bronchial eosinophilia in a murine model of allergic airway inflammation",
  195. (1994). Granulocyte-macrophage colony-stimulating factor, eosinophils and eosinophil cationic protein in subjects with and without mild, stable, atopic asthma",
  196. (1991). Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils",
  197. (2002). Granulocyte/macrophage-colony-stimulating factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through Akt/Erk activation of NFkappa B and AP-1 in vivo",
  198. (2001). Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin8",
  199. (2006). High serum levels of tumour necrosis factor-alpha and interleukin-8 in severe asthma: markers of systemic inflammation?",
  200. (2006). High-resolution computed tomography findings in elderly patients with asthma",
  201. (2005). High-resolution computed tomography imaging of airway disease in infants with cystic fibrosis",
  202. (1988). Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor",
  203. (2007). Histamine and tryptase modulate asthmatic airway smooth muscle GM-CSF and RANTES release",
  204. (1990). Histamine stimulates proliferation of airway smooth muscle and induces c-fos expression",
  205. (1993). Histochemical characteristics and degranulation of mast cells in epithelium and lamina propria of bronchial biopsies from asthmatic and normal subjects. Am Rev Respir Dis
  206. (1993). Histochemical characteristics and degranulation of mast cells in epithelium and lamina propria of bronchial biopsies from asthmatic and normal subjects",
  207. (2004). Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma",
  208. (2004). Host defense function of the airway epithelium in health and disease: clinical background",
  209. (1996). Human blood basophils produce interleukin-13 in response to IgE-receptor-dependent and -independent activation",
  210. (2002). Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP",
  211. (1996). Human lung mast cell activation leads to IL-13 mRNA expression and protein release",
  212. (1998). Human lung mast cells are enriched in the capacity to produce granulocyte-macrophage colony-stimulating factor in response to IgE-dependent stimulation",
  213. (2004). Human neutrophil-derived elastase induces airway smooth muscle cell proliferation",
  214. (2004). Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression",
  215. (2001). Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population",
  216. (1993). Identification of basophils by immunohistochemistry in the airways of post-mortem cases of fatal asthma",
  217. (2003). Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma",
  218. (2007). IL-13 and epidermal growth factor receptor have critical but distinct roles in epithelial cell mucin production",
  219. (2003). IL-13 enhances agonist-evoked calcium signals and contractile responses in airway smooth muscle",
  220. (1995). IL-13 expression at the sites of allergen challenge in patients with asthma",
  221. (1997). IL-13 production by allergen-stimulated T cells is increased in allergic disease and associated with IL-5 but not IFN-gamma expression",
  222. (2006). IL-13 receptor alpha 2: a regulator of IL-13 and IL-4 signal transduction in primary human fibroblasts",
  223. (2008). IL-13 receptor alpha2 selectively inhibits IL-13-induced responses in the murine lung",
  224. (2006). IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis",
  225. (2002). IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle",
  226. (2001). IL-4 and IL-13 induce myofibroblastic phenotype of human lung fibroblasts through c-Jun NH2-terminal kinasedependent pathway",
  227. (1998). IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts",
  228. (2001). IL-4, IL-13, and dexamethasone augment fibroblast proliferation in asthma",
  229. (1995). IL-5, IL-8 and GM-CSF immunostaining of sputum cells in bronchial asthma and chronic bronchitis",
  230. (2007). IL13 promoter polymorphism 1112C/T modulates the adverse effect of tobacco smoking on lung function",
  231. (1999). IL4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo",
  232. (2001). Immuno-regulatory cytokines in asthma: IL-15 and IL-13 in induced sputum",
  233. (1993). Immunohistochemistry on resin sections: a comparison of resin embedding techniques for small mucosal biopsies",
  234. (2008). Immunoregulatory roles of eosinophils: a new look at a familiar cell",
  235. (2003). Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease",
  236. (1992). In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals",
  237. (1993). Increased granulocyte/macrophage colony-stimulating factor production by mononuclear cells from peripheral blood of patients with bronchial asthma",
  238. (2000). Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations",
  239. (2003). Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients",
  240. (2002). Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma. Thorax
  241. (2002). Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma",
  242. (2006). Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma",
  243. (1996). Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements",
  244. (2004). Induced sputum inflammatory mediator concentrations in chronic cough",
  245. (2000). Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma",
  246. (2000). Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema",
  247. (2007). Inflammation of bronchial smooth muscle in allergic asthma. Thorax
  248. (2007). Inflammation of bronchial smooth muscle in allergic asthma",
  249. (2007). Inflammatory cell microlocalisation and airway dysfunction: cause and effect?",
  250. (1997). Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. Am J Respir Crit Care Med
  251. (1997). Inflammatory cells in the bronchial glands of smokers with chronic bronchitis",
  252. (1990). Inflammatory markers in bronchoalveolar lavage and in bronchial biopsy in asthma during remission. Chest
  253. (1990). Inflammatory markers in bronchoalveolar lavage and in bronchial biopsy in asthma during remission",
  254. (2005). Inflammatory process of CD8+CD28- T cells in induced sputum from asthmatic patients.",
  255. (1998). Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease",
  256. (1998). Inhaled steroids in COPD",
  257. (1996). Integrin alpha 4 beta 7 mediates human eosinophil interaction with MAdCAM-1, VCAM-1 and fibronectin",
  258. (1996). Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model",
  259. (1991). Interleukin-1 binds to specific receptors on human bronchial epithelial cells and upregulates granulocyte/macrophage colony-stimulating factor synthesis and release",
  260. (2003). Interleukin-13 and -4 expression in the central airways of smokers with chronic bronchitis",
  261. (1996). Interleukin-13 and interleukin-4 are coexpressed in atopic asthma",
  262. (2005). Interleukin-13 and interleukin-5 in induced sputum of eosinophilic bronchitis: comparison with asthma",
  263. (2003). Interleukin-13 in asthma",
  264. (2002). Interleukin-13 induces a hypersecretory ion transport phenotype in human bronchial epithelial cells",
  265. (2000). Interleukin-13 induces PSGL-1/P-selectin-dependent adhesion of eosinophils, but not neutrophils, to human umbilical vein endothelial cells under flow",
  266. (1993). Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses",
  267. (1998). Interleukin-13: central mediator of allergic asthma",
  268. (2007). Interleukin-13+ Cells Are Present in the Airway Smooth Muscle Bundle of Subjects with
  269. (2005). Interleukin-3, -5, and granulocyte macrophage colony-stimulating factor induce adhesion and chemotaxis of human eosinophils via p38 mitogen-activated protein kinase and nuclear factor kappaB",
  270. (2003). Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma",
  271. (1992). Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects",
  272. (1991). Interleukin-5, interleukin-3, and granulocytemacrophage colony-stimulating factor cross-compete for binding to cell surface receptors on human eosinophils",
  273. (2003). Interleukin-9 influences chemokine release in airway smooth muscle: role of ERK",
  274. (2006). Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease",
  275. (1993). Intraepithelial mast cells in allergic and nonallergic asthma. Assessment using bronchial brushings. Am Rev Respir Dis
  276. (1993). Intraepithelial mast cells in allergic and nonallergic asthma. Assessment using bronchial brushings",
  277. (1996). Intramural elastase injection increases responsiveness of isolated bronchial segments",
  278. (2007). Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study",
  279. (2001). Invited lecture: activation of the epithelial mesenchymal trophic unit in the pathogenesis of asthma",
  280. (1997). Late response to allergen is associated with increased concentrations of tumor necrosis factor-alpha and IL-5 in induced sputum",
  281. (2007). Lipopolysaccharide-induced lung inflammation is inhibited by neutralization of GM-CSF",
  282. Living on a Knife Edge.
  283. (1997). Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function.
  284. (1997). Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function",
  285. (2004). Location, location, location: microlocalisation of inflammatory cells and airway dysfunction",
  286. (2001). Lung epithelial barrier function and wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-gamma",
  287. (2002). Macrophages and the pathogenesis of COPD",
  288. (1992). Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack",
  289. (2003). Marked up-regulation of T lymphocytes and expression of interleukin-9 in bronchial biopsies from patients With chronic bronchitis with obstruction. Chest
  290. (2003). Marked upregulation of T lymphocytes and expression of interleukin-9 in bronchial biopsies from patients With chronic bronchitis with obstruction",
  291. (2006). Mast cell beta-tryptase selectively cleaves eotaxin and RANTES and abrogates their eosinophil chemotactic activities",
  292. (2002). Mast cell chymase modifies cell-matrix interactions and inhibits mitogen-induced proliferation of human airway smooth muscle cells",
  293. (2006). Mast cell migration to Th2 stimulated airway smooth muscle from asthmatics",
  294. (1997). Mast cell numbers are increased in the smooth muscle of human sensitized isolated bronchi",
  295. (2007). Mast cell numbers in airway smooth muscle and PC20AMP in asthma and COPD",
  296. (2008). Mast cell tryptase causes homologous desensitization of beta-adrenoceptors by Ca2+ sensitization in tracheal smooth muscle",
  297. (1996). Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression",
  298. (1997). Mast cell tryptase potentiates histamine-induced contraction in human sensitized bronchus",
  299. (2006). Mast cells express IL-13R alpha 1: IL-13 promotes human lung mast cell proliferation and Fc epsilon RI expression",
  300. (1994). Mast cells in the airway lumen and bronchial mucosa of patients with chronic bronchitis.
  301. (1994). Mast cells in the airway lumen and bronchial mucosa of patients with chronic bronchitis",
  302. (2008). Mast cells promote airway smooth muscle cell differentiation via autocrine up-regulation of TGF-beta 1",
  303. (2006). Mast cells regulate procollagen I (alpha 1) production by bronchial fibroblasts derived from subjects with asthma through IL-4/IL-4 delta 2 ratio",
  304. (2002). Mast-cell infiltration of airway smooth muscle in asthma.
  305. (2002). Mast-cell infiltration of airway smooth muscle in asthma", N.Engl.J.Med.,
  306. (2002). Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cellpolarizing signals",
  307. (1992). Migration of primed human eosinophils across cytokine-activated endothelial cell monolayers",
  308. (1999). Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm",
  309. (1989). Morphometric analysis of intraluminal mucus in airways in chronic obstructive pulmonary disease",
  310. (2002). Mucin-producing elements and inflammatory cells. Novartis Found Symp
  311. (2002). Mucin-producing elements and inflammatory cells",
  312. (1999). Mucosal inflammation in severe glucocorticoiddependent asthma",
  313. (2008). Multiple-dose study of AMG317 in adults with asthma: pharmacokinetics and safety.
  314. (1996). Muscarinic and beta-adrenergic receptor expression in peripheral lung from normal and asthmatic patients",
  315. (1990). Myofibroblasts and subepithelial fibrosis in bronchial asthma",
  316. (2005). Nature of airway inflammation and remodeling in chronic cough",
  317. (1985). Nervous control of mucin secretion into human bronchi",
  318. (2006). Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction",
  319. (1999). Neutrophil elastase increases MUC5AC mRNA and protein expression in respiratory epithelial cells",
  320. (2005). Neutrophil elastase induces MUC5AC mucin production in human airway epithelial cells via a cascade involving protein kinase C, reactive oxygen species, and TNF-alpha-converting enzyme",
  321. (2004). Neutrophilic infiltration within the airway smooth muscle in patients with COPD",
  322. (1999). Neutrophilic inflammation in severe persistent asthma",
  323. (2002). New insights into the relationship between airway inflammation and asthma",
  324. (2003). New insights into the role of the mast cell in asthma",
  325. (2001). Nitric oxide inhibits rhinovirus-induced granulocyte macrophage colony-stimulating factor production in bronchial epithelial cells",
  326. (2005). Nitrosative stress, heme oxygenase-1 expression and airway inflammation during severe exacerbations of COPD",
  327. (2003). Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies",
  328. (2008). Optimized dialysis and protease inhibition of sputum dithiothreitol supernatants",
  329. (1987). Parasympathetic nervous control of tracheal vascular resistance in the dog",
  330. (2007). Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma",
  331. (1954). Pathology of chronic bronchitis",
  332. (2008). Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease",
  333. (2003). Persistent activation of nuclear factorkappaB signaling pathway in severe uncontrolled asthma",
  334. (2008). Pharmacokinetics and local tolerance of an IL-4/IL-13 antagonist inhalation powder in humans.
  335. (1994). Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma",
  336. (2007). Plasma cells and IL-4 in chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med
  337. (2007). Plasma cells and IL-4 in chronic bronchitis and chronic obstructive pulmonary disease",
  338. (2002). Polyclonal and allergen-induced cytokine responses in children with elevated immunoglobulin E but no atopic disease",
  339. (2003). Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study",
  340. (1992). Predominant TH2-like bronchoalveolar Tlymphocyte population in atopic asthma",
  341. (1989). Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation",
  342. (2006). Profiles of proinflammatory cytokines in sputum from different groups of severe asthmatic patients",
  343. (2000). Proinflammatory and Th2-derived cytokines modulate CD40-mediated expression of inflammatory mediators in airway epithelia: implications for the role of epithelial CD40 in airway inflammation",
  344. (2001). Proinflammatory cytokines
  345. (1991). Proinflammatory cytokines in acute asthma",
  346. (1994). Pseudomonas stimulates interleukin-8 mRNA expression selectively in airway epithelium, in gland ducts, and in recruited neutrophils",
  347. (1999). Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production",
  348. (2007). Pulmonary inflammation and emphysema: role of the cytokines IL-18 and IL-13",
  349. (1996). Purified human peripheral blood basophils release interleukin-13 and preformed interleukin-4 following immunological activation",
  350. (1990). Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis
  351. (1990). Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry",
  352. (2005). Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD",
  353. (1998). Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma",
  354. (2000). Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial",
  355. (1999). Receptor clearance obscures the magnitude of granulocyte-macrophage colony-stimulating factor responses in mice to endotoxin or local infections",
  356. (1993). Receptors for granulocytemacrophage colony-stimulating factor, interleukin-3, and interleukin-5",
  357. (1986). Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival",
  358. (2004). Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids",
  359. (1999). Regulation of TH1- and TH2-type cytokine expression and action in atopic asthmatic sensitized airway smooth muscle",
  360. (2004). Regulation of TNF-alpha- and IFN-gamma-induced CXCL10 expression: participation of the airway smooth muscle in the pulmonary inflammatory response in chronic obstructive pulmonary disease",
  361. (2003). Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study",
  362. (2005). Relationship of small airway chymase-positive mast cells and lung function in severe asthma",
  363. Relationship with neutrophils and airway function",
  364. (1993). Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma",
  365. (2006). Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma",
  366. (1997). Release of granulocyte-macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone",
  367. (2001). Remodeling in asthma and chronic obstructive lung disease",
  368. (2001). Remodeling of the airway epithelium in asthma",
  369. (2007). Reported prevalence and co-morbidity of asthma, chronic bronchitis and emphysema: a pan-European estimation",
  370. (1998). Requirement for IL-13 independently of IL-4 in experimental asthma",
  371. (2007). Requirements for T lymphocyte migration in explanted lymph nodes",
  372. (1988). Responsiveness of bronchial smooth muscle from asthmatic patients to relaxant and contractile agonists",
  373. (1999). Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors",
  374. (2004). Rhinovirus 16 3C protease induces interleukin-8 and granulocytemacrophage colony-stimulating factor expression in human bronchial epithelial cells",
  375. (2003). Role of c-jun Nterminal kinase in the induced release of GM-CSF, RANTES and IL-8 from human airway smooth muscle cells",
  376. (2004). Role of microvascular permeability on physiologic differences in asthma and eosinophilic bronchitis",
  377. (2007). Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
  378. (1994). Selective enhancement of GM-CSF, TNF-alpha, IL-1 beta and IL-8 production by monocytes and macrophages of asthmatic subjects",
  379. (2002). Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chain",
  380. (2002). Selective phosphodiesterase type 4 inhibitors reduce the prolonged survival of eosinophils stimulated by granulocytemacrophage colony-stimulating factor",
  381. (2007). Severe asthma in adults: what are the important questions?",
  382. (1998). Severity of airflow limitation is associated with severity of airway inflammation in smokers",
  383. (2004). Sex differences in COPD and lung cancer mortality trends--United States, 1968-1999",
  384. (1999). Signaling domains of the beta c chain of the GM-CSF/IL-3/IL-5 receptor",
  385. (2004). Signaling pathways regulating interleukin-13-stimulated chemokine release from airway smooth muscle",
  386. (2004). Similarities and differences in asthma and COPD. The Dutch hypothesis",
  387. (1968). Site and nature of airway obstruction in chronic obstructive lung disease",
  388. (2001). Smoking and airway inflammation in patients with mild asthma",
  389. (2007). Specificity of basement membrane thickening in severe asthma",
  390. (2004). Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis",
  391. (2000). Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial",
  392. (2005). Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease",
  393. (1998). Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis",
  394. (2004). STAT-1 is activated by IL-4 and IL-13 in multiple cell types",
  395. (2008). Statistical Information System. World Health Statistics
  396. (2005). Structural changes to airway smooth muscle in cystic fibrosis",
  397. (2003). Structure and function of small airways in smokers: relationship between air trapping at CT and airway inflammation. Radiology
  398. (2000). Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease",
  399. (2005). Supplement Thorax Dec 2005; 60: S30 Increased levels of interleukin-13 concentration in induced sputum of severe asthmatics treated with intramuscular
  400. (1999). Synergistic effects of interleukin-4 or interleukin-13 and tumor necrosis factor-alpha on eosinophil activation in vitro",
  401. (2002). T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma",
  402. (1997). Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia",
  403. (1999). The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma",
  404. (2001). The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma",
  405. (1998). The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness",
  406. (2005). The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle",
  407. (2005). The effect of IL-13 and IL-13R130Q, a naturally occurring IL-13 polymorphism, on the gene expression of human airway smooth muscle cells",
  408. (1997). The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation. Am J Respir Crit Care Med
  409. (1997). The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation",
  410. (2008). The effects of IMA-638 on allergen induced airway responses in subjects with mild atopic asthma. ERS Abstract.
  411. (2002). The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study",
  412. (2002). The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a doubleblind, placebo-controlled biopsy study. Am J Respir Crit Care Med
  413. (1991). The eosinophilic injury to the mucosa of the airways in the pathogenesis of bronchial asthma",
  414. (2005). The extracellular deposition of mast cell products is increased in hypertrophic airways smooth muscles in allergic asthma but not in nonallergic asthma",
  415. (2006). The history of COPD",
  416. (1985). The human gene encoding GM-CSF is at 5q21-q32, the chromosome region deleted in the 5q- anomaly",
  417. (1992). The human recombinant ckit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils",
  418. (2008). The impact of the 2004 NICE guideline and
  419. (1992). The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group",
  420. (2004). The nature of smallairway obstruction in chronic obstructive pulmonary disease", N.Engl.J.Med.,
  421. (1978). The relations between structural changes in small airways and pulmonary-function tests",
  422. (2002). The role of mitogen-activated protein kinases in eotaxininduced cytokine production from bronchial epithelial cells",
  423. (2006). The role of the mast cell in the pathophysiology of asthma",
  424. (2007). The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease",
  425. (1993). The structure of large and small airways in nonfatal and fatal asthma",
  426. (2008). The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation",
  427. (1997). The use of induced sputum to investigate airway inflammation",
  428. (2006). Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF)",
  429. (2008). Thoracic Society (BTS)
  430. (2005). Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity.
  431. (2005). Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity",
  432. (1996). Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions",
  433. (1997). Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis",
  434. (2001). Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells",
  435. (2003). Tryptase-stimulated human airway smooth muscle cells induce cytokine synthesis and mast cell chemotaxis.
  436. (1994). Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease",
  437. (1998). Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway",
  438. (2005). Ultrastructure of bronchial biopsies from patients with allergic and non-allergic asthma. Respir Med
  439. (2005). Ultrastructure of bronchial biopsies from patients with allergic and non-allergic asthma",
  440. (1997). Upregulation of alpha GM-CSF-receptor in nonatopic asthma but not in atopic asthma",
  441. (1996). Upregulatory effects of interleukin-4 and interleukin-13 but not interleukin-10 on granulocyte/macrophage colony-stimulating factor production by human bronchial epithelial cells",
  442. (2003). Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone",
  443. (2005). Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma",
  444. (2007). Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis",

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.